Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $45.1B |
| FY2017, ended Dec 31, 2017 | $62.9B |
| FY2018, ended Dec 31, 2018 | $69.8B |
| FY2019, ended Dec 31, 2019 | $102B |
| FY2020, ended Dec 31, 2020 | $99.7B |
| FY2021, ended Dec 31, 2021 | $133B |
| FY2022, ended Dec 31, 2022 | $98.7B |
| FY2023, ended Dec 31, 2023 | $101B |
| FY2024, ended Dec 31, 2024 | $85.7B |
| FY2025, ended Dec 31, 2025 | $81.8B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $75.9B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.79B |
| FY2017, ended Dec 31, 2017 | $6.66B |
| FY2018, ended Dec 31, 2018 | $7.44B |
| FY2019, ended Dec 31, 2019 | $7.58B |
| FY2020, ended Dec 31, 2020 | $8.04B |
| FY2021, ended Dec 31, 2021 | $9.36B |
| FY2022, ended Dec 31, 2022 | $9.65B |
| FY2023, ended Dec 31, 2023 | $10.0B |
| FY2024, ended Dec 31, 2024 | $10.1B |
| FY2025, ended Dec 31, 2025 | $10.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $11.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $956M | $2.02B |
| FY2017, ended Dec 31, 2017 | $1.24B | $2.12B |
| FY2018, ended Dec 31, 2018 | $1.24B | $2.84B |
| FY2019, ended Dec 31, 2019 | $1.89B | $2.76B |
| FY2020, ended Dec 31, 2020 | $1.69B | $2.85B |
| FY2021, ended Dec 31, 2021 | $2.57B | $3.44B |
| FY2022, ended Dec 31, 2022 | $1.77B | $1.82B |
| FY2023, ended Dec 31, 2023 | $1.48B | $2.92B |
| FY2024, ended Dec 31, 2024 | $2.25B | $3.70B |
| FY2025, ended Dec 31, 2025 | $2.53B | $3.78B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.31B | $3.96B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $787M |
| FY2017, ended Dec 31, 2017 | $802M |
| FY2018, ended Dec 31, 2018 | $1.21B |
| FY2019, ended Dec 31, 2019 | $1.50B |
| FY2020, ended Dec 31, 2020 | $1.75B |
| FY2021, ended Dec 31, 2021 | $1.95B |
| FY2022, ended Dec 31, 2022 | $1.55B |
| FY2023, ended Dec 31, 2023 | $1.75B |
| FY2024, ended Dec 31, 2024 | $2.00B |
| FY2025, ended Dec 31, 2025 | $1.47B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.87B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $18.5B |
| FY2017, ended Dec 31, 2017 | $20.2B |
| FY2018, ended Dec 31, 2018 | $21.2B |
| FY2019, ended Dec 31, 2019 | $1.90M |
| FY2020, ended Dec 31, 2020 | $29.3B |
| FY2021, ended Dec 31, 2021 | $43.5B |
| FY2022, ended Dec 31, 2022 | $38.9B |
| FY2023, ended Dec 31, 2023 | $38.8B |
| FY2024, ended Dec 31, 2024 | $36.5B |
| FY2025, ended Dec 31, 2025 | $37.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $37.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 8.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 427M |
| FY2017, ended Dec 31, 2017 | 441M |
| FY2018, ended Dec 31, 2018 | 441M |
| FY2019, ended Dec 31, 2019 | 443M |
| FY2020, ended Dec 31, 2020 | 444M |
| FY2021, ended Dec 31, 2021 | 456M |
| FY2022, ended Dec 31, 2022 | 466M |
| FY2023, ended Dec 31, 2023 | 466M |
| FY2024, ended Dec 31, 2024 | 467M |
| FY2025, ended Dec 31, 2025 | 466M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 464M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $89.9M | $0 |
| FY2017, ended Dec 31, 2017 | $766M | $109M | $0 |
| FY2018, ended Dec 31, 2018 | $233M | $138M | — |
| FY2019, ended Dec 31, 2019 | $19.6M | $111M | $0 |
| FY2020, ended Dec 31, 2020 | $56.0M | $121M | $0 |
| FY2021, ended Dec 31, 2021 | $0 | $120M | $2.36B |
| FY2022, ended Dec 31, 2022 | $18.8M | $169M | $2.29B |
| FY2023, ended Dec 31, 2023 | $0 | $196M | $0 |
| FY2024, ended Dec 31, 2024 | $0 | $204M | $0 |
| FY2025, ended Dec 31, 2025 | $365M | $174M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $868M | $156M | — |
Valuation
At current price- Market Cap
- $85.3B
- P/E
- 25.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 7.7×
- Price / Book
- 24.2×
- EV / EBITDA
- 17.3×
Growth
Trailing 12 months- Revenue (TTM)
- $11.0B
- Revenue Growth YoY
- 5.3%
- Revenue CAGR 3Y
- 3.3%
- Revenue CAGR 5Y
- 5.8%
- EPS Growth YoY
- 13.4%
- Net Income Growth YoY
- 12.8%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 44.8%
- Net Margin
- 30.1%
- FCF Margin
- 36.0%
- Return on Equity
- 88.7%
Earnings
Trailing 12 months- Net Income
- $3.31B
- EPS (diluted)
- $7.11
- EBITDA
- $7.01B
- Operating Income
- $4.94B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $1.87B
- Total Debt
- $37.6B
- Net Debt
- $35.7B
- Total Assets
- $63.0B
- Total Liabilities
- $53.2B
- Shareholders' Equity
- $3.52B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.71B
- Capital Expenditure
- $1.75B
- Free Cash Flow
- $3.96B
Dividends and risk
Last 12 months- Dividend Yield
- 3.8%
- Dividend / Share
- $7.07
- Beta (5Y)
- 0.88
Every ratio is calculated from the company’s reported figures.